<DOC>
	<DOCNO>NCT02540668</DOCNO>
	<brief_summary>The purpose study look much warfarin get blood stream long take body get rid give without AZD3293 . Another purpose evaluate effectiveness warfarin therapy prevent blood clot give AZD3293 measure international normalize ratio ( INR ) . INR measure time take blood clot compare average . Information side effect may occur also collect . The study last 5 week first dose follow-up participant .</brief_summary>
	<brief_title>A Drug Interaction Study AZD3293 ( LY3314814 ) Warfarin Healthy Participants</brief_title>
	<detailed_description />
	<mesh_term>Warfarin</mesh_term>
	<criteria>Male participant : sterile ( include vasectomy ) agree use effective method birth control donate sperm study 3 month follow last dose investigational product Female participant : woman childbearing potential Have history current , significant ophthalmic disease , determine investigator ophthalmologist Have vitiligo clinically significant disorder skin pigmentation determine investigator dermatologist Have history presence significant bleeding disorder Have history gastrointestinal ulcer hemorrhage Have personal family history coagulation bleed disorder reasonable suspicion vascular malformation Selfreported history increase bleed trauma Have history major head trauma ( loss consciousness ) within past year minor head trauma ( without loss consciousness ) within last 3 month prior screen History major surgery within 3 month screen Planned surgery within 14 day last day dose International Normalized Ratio ( INR ) / Prothrombin Time ( PT ) activate partial thromboplastin time normal reference range screen Abnormal Protein S antigen and/or Protein C activity determine investigator History deep vein thrombosis and/or pulmonary embolism</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>